| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MLAB | Common Stock | Options Exercise | $195,560 | +2,000 | +27% | $97.78 | 9,514 | 20 Oct 2021 | Direct | |
| transaction | MLAB | Common Stock | Sale | -$619,720 | -2,000 | -21% | $309.86 | 7,514 | 20 Oct 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MLAB | Non Qualified Stock Option | Exercise of in-the-money or at-the-money derivative security | $0 | -2,000 | -6.1% | $0 | 31,029 | 20 Oct 2021 | Common Stock | 2,000 | $97.78 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | 1/5 exercisable on each anniversary date of the 04-01-2016 grant date |
| F2 | Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 |